razoxane has been researched along with Bronchial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bush, H; Hellmann, K; James, SE; Spittle, MF | 1 |
| Hassenstein, E; Rhomberg, W | 1 |
2 trial(s) available for razoxane and Bronchial Neoplasms
| Article | Year |
|---|---|
Clinical trial of razoxane and radiotherapy for inoperable carcinoma of the bronchus.
Topics: Bronchial Neoplasms; Carcinoma, Small Cell; Clinical Trials as Topic; Esophagitis; Humans; Leukopenia; Piperazines; Radiation Injuries; Radiotherapy, High-Energy; Razoxane | 1979 |
[Combined treatment of lung carcinoma. Report on a prospective randomized study with radiotherapy and ICRF 159 (1,2-(3,5-dioxopiperazines-lyl)propane) (author's transl)].
Topics: Adenocarcinoma; Adult; Aged; Bronchial Neoplasms; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Female; Hematologic Diseases; Humans; Male; Middle Aged; Piperazines; Radioisotope Teletherapy; Radiotherapy Dosage; Radiotherapy, High-Energy; Razoxane | 1977 |